DM Arena URO/Oncology
Denne artikkelen er mer enn fem år gammel.
Dato: Tirsdag 4. september 2018, Oslo Norway kl. 17.00-20.00
Registrering og enkel servering fra kl. 16.30
Sted: Oslo Cancer Cluster, Ullernchausséen 64 (close to Radiumhospitalet)
Kaare Norum Auditorium
Dette DM Arena-møtet er, på grunn av begrenset plass, lukket for legemiddelindustrien og andre kommersielle aktører – med mindre man er sponsor.
16.30: Registration, Coffee and snacks
17.00: Welcome: by Markus Moe (Dagens Medisin)
17.05: Introduction: Jan Oldenburg (Ahus)
17.10: State of the art – trimodal treatment of bladder cancer (last opp)
Prof. Nick James (Professor of Clinical Oncology, Institute of Cancer and Genomic Sciences, University of Birmingham)
(30min talk +10min Q&A)
17.50: Indication for - and timing of cytoreductive nephrectom, Kidney- and bladder cancer: Immunotherapy (last ned)
Prof. Axel Bex, EORTC GU Director, Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands
(30min talk +10min Q&A)
18.30: Break: coffee & snacks (10 min)
18.40: Significant tumors of the prostate: Visualization by ultrasound versus mpMRI and their limitations
Prof. Tillmann Loch, Department of Urology, Diakonissenkrankenhaus Flensburg, Lehrkrankenhaus der Christian-Albrechts-Universität, Marienhölzungsweg, Flensburg, Germany
(30min talk +10min Q&A)
19.20: Treatment of prostate cancer with focus on results from STAMPEDE (last ned)
Prof. Nick James (Professor of Clinical Oncology, Institute of Cancer and Genomic Sciences, University of Birmingham)
(30min talk +10min Q&A)
20.00: End
Sponsorer:
